ARTICLE AUTHORS
ARTICLE INFO
academic journalism

Superselective Embolization of Pseudoaneurysm Following Percutaneous Nephrolithotomy (PCNL)- A Case Reort

AUTHORS

avatar Mohammad Gharib Salehi 1 , avatar Jamal Hoseini 2 , avatar Mahdi Mohammadi 1 , *

1 Dept. of Radiology, School of medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

2 Clinical Research Developmental Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

How to Cite: Gharib Salehi M, Hoseini J, Mohammadi M. Superselective Embolization of Pseudoaneurysm Following Percutaneous Nephrolithotomy (PCNL)- A Case Reort. J Kermanshah Univ Med Sci. 2013;16(7):e77299.

ARTICLE INFORMATION

Journal of Kermanshah University of Medical Sciences: 16 (7); e77299
Published Online: February 27, 2013
Article Type: Case Report
Received: June 04, 2012
Accepted: November 20, 2012
READ FULL TEXT

Abstract

Background: Percutaneous nephrolithotomy (PCNL) for renal calculi is less invasive treatment than open surgery. Vascular complications of this procedure include hematoma, pseudoaneurysm and arteriovenous fistula of which pseudoaneurysm is usually symptomatic 24h after procedure.
Case Report: We report a case of pseudoaneurysm, which was symptomatic within less than 24h following procedure and because of drop in hemoglobin and changes in hemodynamic status and resistance to conservative therapy, was a candidate for renal artery angiography. When definitive diagnosis of pseudoaneurysm was confirmed via angiography, treatment was done successfully by superselective embolization with microcoils and the patient was discharged with good general condition one day later.
Conclusion: Pseudoaneurysm as a rare vascular complication following PCNL , diagnosed by renal angiography within less than 24h and superselective embolization of it was done successfully.

Fulltext

References

  • 1.

    The references of this article is available on PDF

© 2013, Journal of Kermanshah University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
COMMENTS

LEAVE A COMMENT HERE: